NCT02941159 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Arimori S, Nozaki H, Morita K, Arimori K
Case report: the effect of a Chinese herbal medicine, BG-104 in two HIV positive hemophiliacs. Biotherapy. 1993;7(1):55-7.
Holliday I
Traditional medicines in modern societies: an exploration of integrationist options through East Asian experience. J Med Philos. 2003 Jun;28(3):373-89.
Timmermans K
Intellectual property rights and traditional medicine: policy dilemmas at the interface. Soc Sci Med. 2003 Aug;57(4):745-56.

A Phase I Single Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Safety and Tolerability of SF2000SD in Healthy Male Volunteers

Details for clinical trial NCT02941159

Clinical trial NCT02941159 - References